Effectiveness of Group Focused Psychosocial Support for Adults Affected by Humanitarian Crises (GroupPM+)

October 12, 2020 updated by: Brandon A Kohrt, MD, PhD, George Washington University

Effectiveness of Group Focused Psychosocial Support to Improve the Psychosocial Well-being and Functioning of Adults Affected by Humanitarian Crisis in Nepal

This is an effectiveness study of group problem management plus, a low-intensity psychological intervention, delivered in five sessions to adults affected by humanitarian crises. The current study will evaluate the effectiveness of Group Problem Management Plus (PM+).

Study Overview

Detailed Description

Counselling programmes used in many humanitarian settings are often non- specific with unknown efficacy and safety. Only a few interventions in humanitarian crises have been rigorously tested, and most studied interventions focused on posttraumatic stress disorder. Beyond posttraumatic stress disorder, individuals may have a range of problems including depression, anxiety, and not being able to do daily tasks necessary for survival and recovery. However, interventions are often limited since they tend to target only a single outcome, are usually of longer duration (8-16 sessions) or require professionals.

In low resourced settings interventions need to be short of duration, and be carried out by lay people in the communities to make them sustainable and feasible to implement on a broader scale. World Health Organization aims to develop a range of low-intensity scale-able psychological interventions that address these issues, as part of its mental health Gap Action Program. As a first step a simplified psychological intervention Problem Management Plus (PM+) has been developed. It has 4 core features that make the intervention suitable for low resourced setting exposed to adversities. First, it is brief intervention (5-sessions), delivered individually or in groups; second, it can be delivered by paraprofessionals (high school graduates with no mental health experience), using the principle of task shifting/ task sharing; third, it is designed as a trans- diagnostic intervention, addressing a range of client identified emotional (e.g. depression, anxiety, traumatic stress, general stress) and practical problems; fourth, it is designed for people in low-income country communities affected by any kind of adversity (e.g. violence, disasters), not just focusing on a single kind of adversity. Recent PM+ trails in Pakistan and Kenya have indicated PM+ to be effective in diminishing depression and anxiety and improving people's functioning and self- selected, culturally relevant outcomes. Group PM+ has been piloted in a district in Nepal, which was affected by the 2015 earthquakes. The pilot was conducted to gather information about the feasibility, safety and delivery of the intervention in the Nepali community settings; and to identify issues around training, supervision and outcomes measures. The pilot trial was successful in terms of acceptability and feasibility and detecting possible problems of compliance, delivery of the intervention, recruitment and retention. The current definitive study will evaluate the effectiveness of Group PM+ in Nepal through a pragmatic cluster randomized controlled trial.

Study Type

Interventional

Enrollment (Actual)

611

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Morang
      • Biratnagar, Morang, Nepal
        • Transcultural Psychosocial Organization (TPO) Nepal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. score YES to heart-mind problems on heart-mind screener
  2. score >16 on World Health Organization Disability Assessment Scale

Exclusion Criteria:

  1. Presence of a severe mental disorder (e.g., psychosis)
  2. Alcohol use disorder (score >16 on the alcohol use disorders identification test (AUDIT)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group problem management plus
Five sessions of group low intensity psychological intervention
Low intensity group psychological intervention including stress management, behavioral activation, problem solving, and strengthening social support
Active Comparator: Enhanced treatment as usual
Referral to primary health care workers trained in mental health Gap Action Programme.
Referral to primary care workers trained in mental health Gap Action Program Implementation Guide
Other Names:
  • mental health Gap Action Program-Implementation Guide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General psychological distress - General Health Questionnaire
Time Frame: 20-weeks after baseline
12-item measure of general psychological distress, validated in Nepal
20-weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily functioning - World Health Organization Disability Assessment Scale
Time Frame: 20-weeks after baseline
12-item assessment ability to engage in daily activities, previously used in numerous studies in Nepal
20-weeks after baseline
Depression - Patient Health Questionnaire
Time Frame: 20-weeks after baseline
9-item measure of depression symptoms, culturally and clinically validated in Nepal
20-weeks after baseline
Posttraumatic Stress Disorder - Posttraumatic Stress Disorder Checklist
Time Frame: 20-weeks after baseline
8-tem measure of post-traumatic stress symptoms validated for use in Nepal
20-weeks after baseline
Cultural idiom of psychological distress - Heart-Mind Screener
Time Frame: 20-weeks after baseline
2-item locally develop psychological distress screener
20-weeks after baseline
Perceptions of support from family, friends, and others - Multidimensional Scale of Perceived Social Support
Time Frame: 20-weeks after baseline
12-item assessment of perceptions of support from 3 sources: Family, Friends, and a Significant Other
20-weeks after baseline
Somatic symptom burden - Somatic Symptom Scale
Time Frame: 20-weeks after baseline
8-item brief measure of somatic symptom burden
20-weeks after baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reducing Tension Checklist for Problem Management Plus Skills
Time Frame: 20-weeks after baseline
10-item measure of behavioral and psychosocial skills related to coping mechanisms
20-weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mark van Ommeren, PhD, World Health Organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2018

Primary Completion (Actual)

September 30, 2019

Study Completion (Actual)

September 30, 2019

Study Registration Dates

First Submitted

October 31, 2018

First Submitted That Met QC Criteria

November 17, 2018

First Posted (Actual)

November 20, 2018

Study Record Updates

Last Update Posted (Actual)

October 14, 2020

Last Update Submitted That Met QC Criteria

October 12, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This will be shared for full trial.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Group problem management plus

3
Subscribe